Intrinsic Value

Qualigen Therapeutics, Inc. (QLGN)

$0.3199

+0.03 (+9.48%)

Enterprise Value -26,025,023.03
Net Debt 0.90
Equity Value -26,025,023.93
Shares Outstanding 5.07
Equity Value Per Share -5,130,399.54



Because investors are more interested in the value of the company’s shares alone, we’ll deduct net debt from this value to arrive at a fair value of the company’s equity. Fair Value = Enterprise Value – Debt